From: A hierarchical approach employing metabolic and gene expression profiles to identify the pathways that confer cytotoxicity in HepG2 cells
Treatment
C16 Ceramide (pmol/mg protein)
LDH released (%)
Control (BSA)
0.63 ± 0.28 *
1.27 ± 0.48 *
Palmitate
24.44 ± 6.39
4.71 ± 1.67
Fumonisin B1
6.80 ± 2.85 *
5.15 ± 1.38